|
||
 |
||
 |
||
| Medicines That Make a Difference® |
Gastrointestinal (GI) motility dysfunction, a major contributing factor to many disorders of the GI tract, refers to the abnormal rate and coordination of food moving out of the stomach and through the rest of the digestive tract. Reduced GI motility can cause symptoms of bloating, nausea, pain and constipation and can adversely affect quality of life. Disorders of reduced motility include chronic idiopathic constipation, constipation predominant irritable bowel syndrome, functional dyspepsia, and delayed gastric emptying.
Our investigational 5-HT4 receptor agonist compound, TD-5108, is for the treatment of chronic constipation and other disorders related to reduced gastrointestinal motility. The goal of our program is to develop an effective and well-tolerated medicine with once-a-day oral dosing.
|
|
| ©2010 Theravance, Inc. Theravance, the Theravance logo and Medicines That Make a Difference are
registered trademarks of Theravance, Inc. Trademarks, trade names or service marks of other companies appearing on this
website are the property of their respective owners. All rights reserved.
Terms of Use Website Admin Contact Theravance Contact Site Map |
||
|
|
|
By clicking on the link below, you will leave www.theravance.com.